FDA 483 OBSERVATION · #54 OF 1,945 MOST-CITED
Written procedures not established/followed
FDA cited this observation 448 times across 401 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
Written procedures required by the quality system were not established, or were established but not followed — a general finding that the controlling documents for an activity either did not exist or were not adhered to in practice.
Why FDA writes it — Established-and-followed is the two-part test for a written procedure. Failing either half means the activity is not under documented control — so this is one of the most common findings across drug and device operations, and it usually underlies other, more specific observations.
- Establish the written procedures the regulation requires for the activity, with the necessary scope and detail.
- Follow the procedures in practice, and record that they were followed.
- Keep procedures current with actual practice so adherence is achievable.
- Train personnel to the procedures and document the training.
- Procedures exist but practice has drifted from them, so they are not actually followed.
- Required procedures were never established for an activity done informally.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.6× the rate of the average FDA-cited firm (35.7% vs 7.8%), across 401 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
Written procedures are not for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Written procedures are not established and followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Written procedures are not established and followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →